The Nasdaq Biotechnology Index fell by 2.3%. Among the constituent stocks, uniQure NV had the largest decline, reaching 55.76%; Tscan Therapeutics fell by 42.27%; Alvotech dropped by 30.72%; Neurogene decreased by 16.87%. On the other hand, Hutchison China MediTech (HCM) rose by 3.10%, Indivior increased by 4.29%, Acrivon Therapeutics went up by 8.79%, Pyxis Oncology climbed by 11.97%, and Terns Pharmaceuticals surged by 81.84%
The Nasdaq Biotechnology Index fell by 2.3%, with constituent stock uniQure NV currently down 55.76%, Tscan Therapeutics down 42.27%, Alvotech down 30.72%, and Neurogene down 16.87%, the fourth largest decline. Hutchison China MediTech (HCM) rose by 3.10%, ranking fifth, Indivior rose by 4.29%, Acrivon Therapeutics rose by 8.79%, Pyxis Oncology rose by 11.97%, and Terns Pharmaceuticals rose by 81.84%